These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 15138551)

  • 21. Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
    Winarti NW; Argani P; De Marzo AM; Hicks J; Mulyadi K
    Int J Surg Pathol; 2008 Jan; 16(1):66-72. PubMed ID: 18203790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
    Klatte T; Streubel B; Wrba F; Remzi M; Krammer B; de Martino M; Waldert M; Marberger M; Susani M; Haitel A
    Am J Clin Pathol; 2012 May; 137(5):761-8. PubMed ID: 22523215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome.
    Mir MC; Trilla E; de Torres IM; Panizo A; Zlotta AR; Van Rhijn B; Morote J
    BJU Int; 2011 Jul; 108(2 Pt 2):E71-6. PubMed ID: 21070573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
    Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal cell carcinoma associated with TFE3 gene fusion in an elderly woman.
    LaGrange CA; Lele SM; Strup SE
    Urology; 2007 Sep; 70(3):590.e11-2. PubMed ID: 17905124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translocation carcinomas of the kidney.
    Argani P; Ladanyi M
    Clin Lab Med; 2005 Jun; 25(2):363-78. PubMed ID: 15848741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear localization and transactivating capacities of the papillary renal cell carcinoma-associated TFE3 and PRCC (fusion) proteins.
    Weterman MJ; van Groningen JJ; Jansen A; van Kessel AG
    Oncogene; 2000 Jan; 19(1):69-74. PubMed ID: 10644981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further characterization of the human clear cell sarcoma cell line HS-MM demonstrating a specific t(12;22)(q13;q12) translocation and hybrid EWS/ATF-1 transcript.
    Sonobe H; Takeuchi T; Taguchi T; Shimizu K; Iwata J; Furihata M; Ohtsuki Y
    J Pathol; 1999 Apr; 187(5):594-7. PubMed ID: 10398127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family.
    Ramphal R; Pappo A; Zielenska M; Grant R; Ngan BY
    Am J Clin Pathol; 2006 Sep; 126(3):349-64. PubMed ID: 16880148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal cell carcinomas with t(6;11)(p21;q12): A clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization.
    Rao Q; Liu B; Cheng L; Zhu Y; Shi QL; Wu B; Jiang SJ; Wang Y; Wang X; Yu B; Zhang RS; Ma HH; Lu ZF; Tu P; Wang JD; Zhou XJ
    Am J Surg Pathol; 2012 Sep; 36(9):1327-38. PubMed ID: 22895266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment and characterization of a novel myxofibrosarcoma cell line.
    Kawashima H; Ogose A; Gu W; Nishio J; Kudo N; Kondo N; Hotta T; Umezu H; Tohyama T; Nishijima H; Iwasaki H; Endo N
    Cancer Genet Cytogenet; 2005 Aug; 161(1):28-35. PubMed ID: 16080955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translocation carcinoma of the kidney.
    Paras FA; MacLennan GT
    J Urol; 2008 May; 179(5):2007. PubMed ID: 18355851
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma.
    Hoshino M; Ogose A; Kawashima H; Izumi T; Hotta T; Hatano H; Morita T; Otsuka H; Umezu H; Yanoma S; Tsukuda M; Endo N
    Cancer Genet Cytogenet; 2009 Apr; 190(2):75-80. PubMed ID: 19380023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PSF-TFE3 oncoprotein in papillary renal cell carcinoma inactivates TFE3 and p53 through cytoplasmic sequestration.
    Mathur M; Das S; Samuels HH
    Oncogene; 2003 Aug; 22(32):5031-44. PubMed ID: 12902986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of an ASPL-TFE3 renal cell carcinoma cell line (S-TFE).
    Hirobe M; Masumori N; Tanaka T; Kitamura H; Tsukamoto T
    Cancer Biol Ther; 2013 Jun; 14(6):502-10. PubMed ID: 23760492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear translocation of ASPL-TFE3 fusion protein creates favorable metabolism by mediating autophagy in translocation renal cell carcinoma.
    Fang R; Wang X; Xia Q; Zhao M; Zhang H; Wang X; Ye S; Cheng K; Liang Y; Cheng Y; Gu Y; Rao Q
    Oncogene; 2021 May; 40(18):3303-3317. PubMed ID: 33846569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal cell carcinoma with t(X;17)(p11.2;q25) in a 6-year-old Taiwanese boy.
    Chen CK; Hsueh C; Lai JY; Hung IJ; Whang-Peng J; Wang WP; Lai HY; Chen JR
    Virchows Arch; 2007 Feb; 450(2):215-9. PubMed ID: 17149613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas.
    Weterman MA; van Groningen JJ; Tertoolen L; van Kessel AG
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13808-13. PubMed ID: 11717438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.
    Chen X; Yang Y; Gan W; Xu L; Ye Q; Guo H
    Medicine (Baltimore); 2015 May; 94(19):e873. PubMed ID: 25984679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of alveolar soft part sarcoma.
    Vistica DT; Krosky PM; Kenney S; Raffeld M; Shoemaker RH
    J Pediatr Hematol Oncol; 2008 Jan; 30(1):46-52. PubMed ID: 18176180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.